Processing of galanin requires the presence of prohormone convertase 1 and prohormone convertase 2 and secretory granules

1995 ◽  
Vol 57 (2) ◽  
pp. 198
Endocrinology ◽  
1999 ◽  
Vol 140 (10) ◽  
pp. 4800-4808 ◽  
Author(s):  
Anders B. Damholt ◽  
Alison M. J. Buchan ◽  
Jens J. Holst ◽  
Hans Kofod

Endocrinology ◽  
2003 ◽  
Vol 144 (1) ◽  
pp. 292-298 ◽  
Author(s):  
Niamh X. Cawley ◽  
Yazmin M. Rodriguez ◽  
Alex Maldonado ◽  
Y. Peng Loh

Abstract We have reinvestigated the stability and intracellular routing of mutant carboxypeptidase E in NIT3 cells, a pancreatic β-cell line derived from the Cpefat/Cpefat mouse. Pulse-chase experiments demonstrated that this protein has a half-life of approximately 3 h in these cells and that up to 45% of the proCPE(202) can escape degradation by the proteosome. In double-label immunofluorescence microscopy, a portion of the mutant CPE did not colocalize with calnexin, an endoplasmic reticulum marker, but was found in prohormone convertase 2-containing secretory granules, demonstrating that it had escaped degradation and arrived at a post-Golgi compartment. The mutant CPE as well as prohormone convertase 2 were secreted into the medium in a stimulated manner by treatment with the physiological secretagogue, glucagon-like peptide-1, consistent with its presence in granules of the regulated secretory pathway. The presence of mutant carboxypeptidase E in granules supports a potential role for its involvement as a sorting/retention receptor in the trafficking of proinsulin to the regulated secretory pathway.


2013 ◽  
Vol 8 (S 01) ◽  
Author(s):  
S Behrendt ◽  
D Löffler ◽  
R Tauscher ◽  
A Körner

2010 ◽  
Vol 36 ◽  
pp. A2-A3
Author(s):  
H. Choquet ◽  
J. Creemers ◽  
M. Pigeyre ◽  
V. Vatin ◽  
B. Balkau ◽  
...  

Author(s):  
Randall H. Renegar ◽  
Charles R. Owens ◽  
Guoli Dai ◽  
John P. McMurtry ◽  
Simon C.M. Kwok

2006 ◽  
Vol 173 (2) ◽  
pp. 241-251 ◽  
Author(s):  
Malika Ahras ◽  
Grant P. Otto ◽  
Sharon A. Tooze

In neuroendocrine PC12 cells, immature secretory granules (ISGs) mature through homotypic fusion and membrane remodeling. We present evidence that the ISG-localized synaptotagmin IV (Syt IV) is involved in ISG maturation. Using an in vitro homotypic fusion assay, we show that the cytoplasmic domain (CD) of Syt IV, but not of Syt I, VII, or IX, inhibits ISG homotypic fusion. Moreover, Syt IV CD binds specifically to ISGs and not to mature secretory granules (MSGs), and Syt IV binds to syntaxin 6, a SNARE protein that is involved in ISG maturation. ISG homotypic fusion was inhibited in vivo by small interfering RNA–mediated depletion of Syt IV. Furthermore, the Syt IV CD, as well as Syt IV depletion, reduces secretogranin II (SgII) processing by prohormone convertase 2 (PC2). PC2 is found mostly in the proform, suggesting that activation of PC2 is also inhibited. Granule formation, and the sorting of SgII and PC2 from the trans-Golgi network into ISGs and MSGs, however, is not affected. We conclude that Syt IV is an essential component for secretory granule maturation.


Endocrinology ◽  
2004 ◽  
Vol 145 (4) ◽  
pp. 1961-1971 ◽  
Author(s):  
Arunangsu Dey ◽  
Christina Norrbom ◽  
Xiaorong Zhu ◽  
Jeffrey Stein ◽  
Chunling Zhang ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document